Lab Tests · COA library

Every batch, independently verified.

A sample from every production batch is sent to a third-party analytical laboratory. The published Certificate of Analysis covers identity, purity, and method — match it to the batch number printed on your vial.
Recent reports

Published Certificates of Analysis

All reports are from a single accredited third-party HPLC laboratory. Reports are archived for two years and remain available even after a batch sells out.
10mg
Semax
Purity:
99.73%
Accession #:
2608190769
10mg/10mg
BPC-157/TB-500
Purity:
99.66%
Accession #:
2608190766
5mg
BPC-157
Purity:
99.14%
Accession #:
2608190742
5mg
TB-500
Purity:
99.46%
Accession #:
2608190745
5mg
CJC-1295 (No DAC)
Purity:
99.80%
Accession #:
2608190751
40mg
Epitalon
Purity:
99.80%
Accession #:
2608190757
10mg
Ipamorelin
Purity:
99.73%
Accession #:
2608190775
80mg
KLOW
Purity:
99.61%
Accession #:
2608190763
40mg
MOTS-c
Purity:
99.50%
Accession #:
2608190754
30mg
GLP TZ
Purity:
99.93%
Accession #:
2608190739
10mg
Tesamorelin
Purity:
99.90%
Accession #:
2608190748
30mg
GLP RT
Purity:
99.85%
Accession #:
2608190736
Methodology

What each report covers

Standard panel for every peptide batch — identity, purity, residual solvent, and microbial.

Identity by mass spectrometry

Confirms the material in the vial is the compound on the label, matched against a reference standard by intact-mass and fragmentation pattern.

Purity by HPLC

The share of the sample that is the target compound, reported as a percentage. Threshold for release: >99% for synthetic peptides.

Residual solvent

Traces of the solvents used during synthesis (acetonitrile, methanol, TFA). Reported in ppm against ICH Q3C limits.

Microbial & endotoxin

Endotoxin (LAL) and bioburden panels run on every batch. Limits aligned with parenteral-grade research material.
Lab access

Need the full analytical package?

Researchers and labs ordering in bulk can request the full method package — including chromatograms, mass-spec traces, and chain-of-custody documentation.